This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Bernstein Liebhard LLP
The Firm is currently investigating Zoloft lawsuits on behalf of victims of alleged Zoloft birth defects.
New York, New York (PRWEB) March 10, 2013
Zoloft lawsuits pending in a multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania, are heading towards discovery, Bernstein Liebhard LLP reports. According to a Pretrial Order dated February 28th, the federal judge overseeing the Zoloft birth defects litigation has appointed a Special Discovery Master to work with the parties to coordinate discovery. Seventy-five Zoloft lawsuits have been transferred to the Eastern District of Pennsylvania since the litigation was established last spring, and another 180 claims have been filed there directly, according to the Order. (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation - MDL 2342)
“We continue to hear from families whose children have been stricken with alleged Zoloft birth defects. We are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Zoloft lawsuit consultations to victims of birth defects allegedly associated with the drug.
Zoloft Birth Defects
Zoloft is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. All of the Zoloft lawsuits pending in the Eastern District of Pennsylvania allege that use of Zoloft during pregnancy can increase the risk of delivering a child with severe birth defects, including pulmonary hypertension in newborns (PPHN), spina bifida and other neural tube defects, heart defects, abdominal defects, and club foot. In November 2006, the FDA added warnings about a potential risk of persistent pulmonary hypertension in newborns (PPHN) from Zoloft and other SSRI antidepressants when taken after the 20th week of pregnancy.* A second study published in the British Medical Journal in September 2009 found that SSRI antidepressants like Zoloft increase the risk of heart defects when taken during the first trimester.**
Victims of possible Zoloft side effects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about alleged Zoloft birth defects please visit Bernstein Liebhard LLP’s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today by calling (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebzoloft-lawsuits/zoloft-birth-defects/prweb10516060.htm